CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,044 | -25.0% | 267,476 | 0.0% | 0.00% | – |
| Q2 2023 | $460,059 | +13.9% | 267,476 | 0.0% | 0.00% | – |
| Q1 2023 | $403,889 | -43.6% | 267,476 | -40.3% | 0.00% | – |
| Q4 2022 | $716,724 | +120.5% | 447,952 | +100.0% | 0.00% | – |
| Q3 2022 | $325,000 | -20.7% | 223,976 | 0.0% | 0.00% | – |
| Q2 2022 | $410,000 | -87.2% | 223,976 | -81.3% | 0.00% | – |
| Q1 2022 | $3,200,000 | -73.0% | 1,198,682 | -56.2% | 0.00% | -100.0% |
| Q4 2021 | $11,862,000 | -42.3% | 2,739,544 | -32.1% | 0.00% | 0.0% |
| Q3 2021 | $20,548,000 | -29.7% | 4,036,937 | -12.6% | 0.00% | -50.0% |
| Q2 2021 | $29,223,000 | +12.6% | 4,616,562 | +37.4% | 0.00% | +100.0% |
| Q1 2021 | $25,964,000 | +93.3% | 3,358,865 | +63.8% | 0.00% | 0.0% |
| Q4 2020 | $13,431,000 | -6.0% | 2,050,597 | -4.6% | 0.00% | 0.0% |
| Q3 2020 | $14,293,000 | -21.9% | 2,149,254 | -2.1% | 0.00% | 0.0% |
| Q2 2020 | $18,290,000 | +141.6% | 2,195,649 | +122.5% | 0.00% | 0.0% |
| Q1 2020 | $7,570,000 | -7.9% | 986,948 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $8,223,000 | -27.7% | 989,570 | -35.8% | 0.00% | 0.0% |
| Q3 2019 | $11,370,000 | -41.5% | 1,540,689 | -11.1% | 0.00% | 0.0% |
| Q2 2019 | $19,449,000 | -13.6% | 1,733,453 | -17.2% | 0.00% | -50.0% |
| Q1 2019 | $22,516,000 | -3.2% | 2,094,485 | +36.0% | 0.00% | 0.0% |
| Q4 2018 | $23,253,000 | -36.6% | 1,539,950 | -22.3% | 0.00% | -33.3% |
| Q3 2018 | $36,658,000 | -6.3% | 1,981,550 | +15.7% | 0.00% | 0.0% |
| Q2 2018 | $39,138,000 | +19.3% | 1,712,121 | +48.5% | 0.00% | 0.0% |
| Q1 2018 | $32,805,000 | +42.3% | 1,152,958 | +5.6% | 0.00% | +50.0% |
| Q4 2017 | $23,047,000 | +48.5% | 1,091,816 | +27.8% | 0.00% | +100.0% |
| Q3 2017 | $15,521,000 | +124.5% | 854,018 | +91.3% | 0.00% | 0.0% |
| Q2 2017 | $6,914,000 | +42.5% | 446,315 | +58.8% | 0.00% | – |
| Q1 2017 | $4,852,000 | +60.3% | 280,973 | +2.0% | 0.00% | – |
| Q4 2016 | $3,027,000 | -28.7% | 275,483 | +1.7% | 0.00% | – |
| Q3 2016 | $4,248,000 | +63.4% | 270,887 | +6.4% | 0.00% | – |
| Q2 2016 | $2,599,000 | +119.9% | 254,501 | +177.3% | 0.00% | – |
| Q1 2016 | $1,182,000 | -16.8% | 91,777 | +34.8% | 0.00% | – |
| Q4 2015 | $1,421,000 | – | 68,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |